Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda in classic or endemic Kaposi's sarcoma
NCT03469804Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2018
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in Kaposi's sarcoma (KS), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
03
Conditions
Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT03469804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03469804.